Diagnostic Utility of SGLT2 Inhibition to Facilitate Myocardial Glucose Suppression During Evaluation of Cardiac Inflammation on FDG-PET
Clinical Trial Grant
Administered By
Duke Molecular Physiology Institute
Awarded By
The Foundation for Sarcoidosis Research
Start Date
January 3, 2024
End Date
January 31, 2026
Administered By
Duke Molecular Physiology Institute
Awarded By
The Foundation for Sarcoidosis Research
Start Date
January 3, 2024
End Date
January 31, 2026